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Abstract
Background: Chlorella, a unicellular green alga that grows in fresh water, contains high levels of proteins, vitamins,
minerals, and dietary fibers. Some studies have reported favorable immune function-related effects on biological
secretions such as blood and breast milk in humans who have ingested a chlorella-derived multicomponent
supplement. However, the effects of chlorella-derived supplement on mucosal immune functions remain unclear.
The purpose of this study was to investigate whether chlorella ingestion increases the salivary secretory
immunoglobulin A (SIgA) secretion in humans using a blind, randomized, crossover study design.
Methods: Fifteen men took 30 placebo and 30 chlorella tablets per day for 4 weeks separated by a 12-week
washout period. Before and after each trial, saliva samples were collected from a sterile cotton ball that was
chewed after overnight fasting. Salivary SIgA concentrations were measured using ELISA.
Results: Compliance rates for placebo and chlorella ingestions were 97.0 ± 1.0% and 95.3 ± 1.6%, respectively. No
difference was observed in salivary SIgA concentrations before and after placebo ingestion (P = 0.38). However,
salivary SIgA concentrations were significantly elevated after chlorella ingestion compared to baseline (P < 0.01). No
trial × period interaction was identified for the saliva flow rates. Although the SIgA secretion rate was not affected by
placebo ingestion (P = 0.36), it significantly increased after 4-week chlorella ingestion than before intake (P < 0.01).
Conclusions: These results suggest 4-week ingestion of a chlorella-derived multicomponent supplement increases
salivary SIgA secretion and possibly improves mucosal immune function in humans.
Introduction
Protein-calorie [1-3], vitamin [4-6], iron [7], and folate
[8] malnutrition has been reported to cause immune defi-
ciencies. Undernutrition is not unique to developing
nations. Furthermore, in developed countries, the total
food energy intake decreases with age [9] because of
social [10], psychological [11,12], and medical factors
[13]. The nutritional status of young adults declines
because of various factors such as skipping breakfast
[14,15], relying on fast food [16,17], and dieting to
achieve a thin body [18,19]. One of the most efficient
methods to improve the nutritional status is use of diet-
ary supplements. However, it is not easy for the general
public to choose suitable supplements for improving
their individual nutritional status. For individuals with
inadequate eating habits, multicomponent dietary supple-
ments that can improve the overall immune function
may be beneficial.
Chlorella, a unicellular green alga that grows in fresh
water, contains high levels of proteins, chlorophylls, vita-
mins, minerals, and dietary fibers. This is an important
advantage as an ingredient of dietary supplement. It is
possible that the multicomponent dietary supplement
acts to correct some underlying nutrient/nutrients defi-
ciency and hence gets the positive outcomes such as
immunoenhancing effects. Indeed, chlorella-derived
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supplements are widely used [20] and believed to
enhance immune function [21,22]. A previous study has
investigated serum antibody titers against influenza and
shown the immunoenhancing effects of chlorella inges-
tion in middle-aged healthy adults [22]. Furthermore,
supplementation with chlorella has been reported to
increase the concentration of secretory immunoglobulin
A (SIgA) in breast milk [21]. However, to the best of our
knowledge, no studies regarding the effects of chlorella
supplementation on salivary or intestinal-fluid SIgA have
been reported. SIgA plays a crucial role in mucosal
immune function and is the first line of defense for the
human body against pathogenic microbial invasion [23].
Previous studies have reported an association between
SIgA concentrations and risks of infection [24-26].
Therefore, it is of interest whether oral supplementation
with chlorella can increase the salivary or intestinal-fluid
SIgA secretion.
We hypothesized that ingestion of a chlorella-derived
multicomponent supplement enhances mucosal immune
functions. To test this hypothesis, we investigated the
effects of 4-week placebo/chlorella supplementation on
salivary SIgA secretion in young men using a blind, rando-
mized, crossover study design. In the previous studies
regarding the immunoenhancing effects of chlorella-
derived dietary supplements, the placebo capsule was
made from microcrystalline cellulose [22] or no restriction
was imposed on the control group [21]. According to
these studies, we attempted to make a large difference in
nutritive values between the placebo and chlorella tablets
based on the idea that the advantage of chlorella as a diet-
ary supplement is to contain various nutrients.
Methods
Participants
Fifteen men volunteered to participate in this study; none
of them used dietary supplements on a regular basis. The
participants were asked not to change their regular life-
styles while taking the placebo/chlorella tablets during the
experimental periods. None of the participants had any
sign, symptom, and history of overt chronic diseases.
Furthermore, none of them was taking any medication and
had a history of smoking. The mean (± SE) age and height
values were 20.4 (0.3) y and 1.68 (0.01) m, respectively.
The present study was approved by the Ethical Com-
mittee of the Institute of Health and Sport Sciences of
the University of Tsukuba. This study conformed to the
principles outlined in the Helsinki Declaration. All parti-
cipants gave their written informed consent before inclu-
sion in this study.
Experimental design
The participants took part in two trials -placebo and
chlorella- in a randomized order. Saliva samples were
obtained from the participants after overnight fasting
according to methods described in our previous studies
[27,28]. From next day, the participants took 30 placebo
or 30 chlorella (SunChlorella A; SunChlorella, Kyoto,
Japan) tablets per day for 4 weeks. Saliva samples were
collected again on the day following the final ingestion.
Compliances with the prescription were documented via
ingestion logs. After a washout period of at least
12 weeks, the second trial commenced and the proce-
dures were same as those in the first trial.
Placebo and chlorella tablets
The mass of the placebo tablet was 243 mg/tablet and that
of the chlorella tablet was 200 mg/tablet. The placebo
tablets were made according to following procedures.
First, a blend of lactose (82.5%) and colorant (17.5%) was
dissolved in purified water and dried. Next, this dry matter
(95%) was mixed with sucrose fatty acid ester (5%) and
converted to tablets. The chlorella tablets contained dried
chlorella pyrenoidosa powder as the main ingredient.
Nutritional values of these tablets are shown in Table 1.
Saliva samples
Before the samplings, subjects refrained from alcohol
consumption and intense physical activity (exercise) for
24 h to avoid immediate (acute) physiological effects.
After overnight fasting, saliva samples were obtained in a
quiet, temperature-controlled room as previously
described [27,28]. Briefly, participants rinsed their
mouths with distilled water (30 s × 3 times) and then
rested for at least 5 min. Saliva production was stimu-
lated by chewing sterilized cotton (Salivette; Sarstedt,
Nümbrecht, Germany) at a frequency of 60 chews/60 s.
The amount of saliva in grams was converted to millili-
ters assuming a saliva density of 1 g/mL. The obtained
saliva samples were separated from the cottons by centri-
fuging at 1,460 g. After measurement of the sample
volume, saliva samples were frozen at -60°C. We mea-
sured salivary SIgA concentrations using ELISA in accor-
dance with the procedures reported in our previous
studies [27,28]. The SIgA secretion rate (μg/min) was
Table 1 Nutritional values of placebo and chlorella
tablets
Placebo Chlorella
Energy, kcal/100 g 406 399
Moisture, g/100 g 3.2 5.3
Protein, g/100 g 2.0 60.8
Lipid, g/100 g 5.9 9.2
Saccharide, g/100 g 85.6 6.3
Dietary fiber, g/100 g 1.1 11.9
Ash, g/100 g 2.2 6.5
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calculated by multiplying the absolute SIgA concentra-
tion (μg/mL) with the saliva flow rate (mL/min).
Statistical analysis
Data are expressed as mean ± SE. Differences in the
actual periods of supplementation and compliances with
the ingestion protocol between the placebo and chlorella
trials were tested using an unpaired t-test. To compare
the effects of ingestion between the placebo and chlorella
trials, statistical analysis was performed using repeated-
measures two-way ANOVA (trial × period). In the case
of a significant trial × period interaction, a post hoc test
(Bonferroni-Dunn) was used to identify the effect of pla-
cebo/chlorella ingestion. P < 0.05 was accepted as
significant.
Results
The periods of ingestion did not differ between the pla-
cebo (4.2 ± 0.1 wk) and chlorella (4.2 ± 0.2 wk) trials
(t = 0.3, P = 0.73). Furthermore, compliances were com-
parable between the placebo (97.0 ± 1.0%) and chlorella
(95.3 ± 1.6%) trials (t = 0.9, P = 0.36). Table 2 shows
the body weights, lean body weights, body fat percen-
tages, and body mass indices of participants before and
after oral supplementation. No trial × period interaction
was observed in these indices (body weight, F = 0.2 and
P = 0.69; lean body weight, F = 0.2 and P = 0.67; body
fat percentage, F = 0.0 and P = 0.98; body mass index,
F = 0.1 and P = 0.70).
Figure 1A demonstrates salivary SIgA concentrations
before and after 4-week placebo/chlorella supplementa-
tion. Trial × period interaction was identified for salivary
SIgA concentrations (F = 5.9, P = 0.02). Oral supple-
mentation with placebo did not affect salivary SIgA con-
centration (P = 0.38), but its concentration significantly
increased after chlorella ingestion compared to that
before ingestion (P < 0.01).
As described in Figure 1B, no trial × period interaction
was identified for saliva flow rates (F = 0.2, P = 0.64).
SIgA secretion rates before and after 4-week placebo/
chlorella ingestion are shown in Figure 1C. ANOVA
revealed a trial × period interaction (F = 5.3, P = 0.02).
While no difference was observed in salivary SIgA secretion
rates between before and after placebo supplementation
(P = 0.36), it significantly increased after chlorella intake
compared to baseline in multiple comparisons (P < 0.01).
Discussion
We investigated the effects of 4-week ingestion of a
chlorella-derived multicomponent supplement on sali-
vary SIgA secretion using a blind, randomized, crossover
study design. This is a first study to evaluate the effects
of chlorella-derived supplement on mucosal immune
functions in humans. The salient finding of this study is
that both salivary SIgA concentration and secretion rate
increased after 4-week chlorella supplementation com-
pared to baseline. Similar changes were not identified in
the placebo trial. We therefore concluded that oral sup-
plementation with a chlorella-derived multicomponent
supplement enhances mucosal immune function.
Salivary SIgA secretion was used to investigate the
immunoenhancing effect of ingestion of a chlorella-
derived multicomponent supplement. Salivary SIgA is the
first line of defense against respiratory tract infections
such as pneumonia and influenza [23]. Klentrou et al.
[24] reported that an increase in salivary SIgA concentra-
tion following 12 weeks of moderate exercise was related
to a decrease in a number of sick days. Furthermore,
Gleeson et al. [25] reported that a mean salivary SIgA
concentration during a 7-month training period of elite
swimmers was associated with a number of infections
contracted during this period. Therefore, we believe that
salivary SIgA concentrations and secretion rates are valid
indices of mucosal immune function.
Several factors are responsible for reductions in nutri-
ents and calorie intakes. Many studies have pointed out
that a diminished sense of smell and taste, increased
cytokine activity, altered gastrointestinal function, and
altered hormone secretion may induce anorexia even in
healthy older adults [29,30]. Further, adverse social fac-
tors such as loneliness [10], psychological factors such as
depression [11,12], and medical factors such as poor den-
tition [13] may also cause undernutrition in older adults.
In young adults, contributing factors include skipping
breakfast [14,15], relying on fast food [16,17], and dieting
to achieve a thin body [18,19]. In particular, university
students living away from home and those who have a
sedentary lifestyle are at a higher risk of poor nutrition
Table 2 Body weight, lean body weight, body fat percentage, and body mass index before and after oral
supplementations with placebo/chlorella
Body weight, kg Lean Body Weight, kg Body fat, % Body Mass Index
Placebo Before 65.1 ± 2.1 52.9 ± 1.5 18.3 ± 1.6 23.1 ± 0.8
After 65.7 ± 2.2 53.3 ± 1.4 18.3 ± 1.7 23.3 ± 0.7
Chlorella Before 64.7 ± 2.3 52.7 ± 1.4 17.9 ± 1.7 22.9 ± 0.8
After 65.1 ± 2.3 53.0 ± 1.4 17.9 ± 1.7 23.0 ± 0.8
Values are means ± SEM.
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than students who live at home and participate in sport-
ing activities [31]. The majority of the participants in this
study were university students. There exists a possibility
that the participants had inadequate nutritional status
and the nutrients in the chlorella-derived supplement
attenuated their health problems. We can speculate, from
lean body weight, body fat, and body mass index, that
total calorie and protein intakes in the subjects were not
insufficient. However, we could not investigate their eat-
ing habits and perform any blood chemical analysis. One
of the next steps is to clarify the mechanisms responsible
for the chlorella ingestion-induced increase in salivary
SIgA secretion.
This study has following limitations. First, we could not
investigate eating habits and perform any blood chemical
analysis as mentioned above. Second, we have no data
describing clinical significance of change in salivary SIgA
secretion. Although it is possible that the dietary supple-
ment-related additional antibodies in healthy young
humans elevate a reserve of immune function, it may not
improve their infection rate at normal condition. Interven-
tion studies in humans with reduced salivary SIgA level
like athletes during training camp and older humans are
needed. This study is an initial step to elucidate the effects
of chlorella-derived supplement on mucosal immune func-
tions. Recently, Yamauchi et al. [26] reported an expres-
sion of Epstein-Barr virus-DNA in saliva and an increase
in a number of upper respiratory symptoms occurred on
the following day of approximately 23 percent reduction
in salivary SIgA secretion rate, although this reduction was
smaller than the increase by the chlorella supplementation
in our study (41%). Again, the salivary SIgA secretion rate
after the chlorella ingestion was 37 percent greater than
that after the placebo intake. Therefore, we consider the
elevation of salivary SIgA secretion rate in the chlorella
trial was clinically significant. Third, we obtained saliva in
the morning to equalize the conditions of subject among
four sampling points (placebo or chlorella trials × before
and after ingestions) although salivary SIgA level is not
stable in the morning especially during 10 min after awa-
kening [32]. The saliva collection in this study was per-
formed at least 1 hour after awakening, however, we can







































































Figure 1 Effects of supplementation with chlorella-derived
multicomponent supplement on mucosal immune function.
These figures show salivary secretory immunoglobulin A (SIgA)
concentrations (A), saliva flow rates (B), and salivary SIgA secretion
rates (C) before and after 4-week placebo (n = 15)/chlorella (n = 15)
ingestion. While no difference was observed in salivary SIgA
concentrations and secretion rates between before and after
placebo supplementation, these indices significantly increased after
chlorella intake compared to baseline. The saliva flow rates did not
change after supplementation with placebo or chlorella compared
to those before intervention. Data are expressed as mean ± SE. *,
significant change compared to before ingestion.
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Conclusion
We concluded that ingestion of a chlorella-derived multi-
component supplement increases salivary SIgA secretion
and possibly enhances mucosal immune function.
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